Epigenetic Drug Discovery
Book Details
Format
Hardback or Cased Book
Book Series
Drug Discovery Series
ISBN-10
1837671109
ISBN-13
9781837671106
Publisher
Royal Society of Chemistry
Imprint
Royal Society of Chemistry
Country of Manufacture
GB
Country of Publication
GB
Publication Date
Sep 30th, 2024
Print length
674 Pages
Weight
1,210 grams
Dimensions
16.40 x 24.20 x 4.30 cms
Ksh 35,800.00
Werezi Extended Catalogue
0 in stock
Delivery Location
Delivery fee: Select location
Secure
Quality
Fast
Focussing on major developments and new technologies, this book provides an overview of the key topics adopted in current epigenetic drug discovery programmes. An ideal resource for researchers with an interest in epigenetic and genetic factors involved in drug discovery, target ID and validation.
Epigenetics is one of the fastest moving fields in drug discovery, with almost every large pharmaceutical company, and a substantial number of biotechnology companies, targeting epigenetic processes to treat diseases ranging from cancer to Huntington’s disease and from inflammation to sickle cell anaemia. This book aims to provide an overview of the key topics adopted in current epigenetic drug discovery programmes with a focus on major developments and new technologies. Importantly, the book incorporates case studies and outlines the key challenges and techniques employed to overcome them. The book is an ideal resource for researchers in both industry and academia with an interest in epigenetic and genetic factors involved in drug discovery, target ID and validation. The book is also an excellent introduction for postgraduates interested in the interface between epigenetics and pharmaceuticals.
Get Epigenetic Drug Discovery by at the best price and quality guaranteed only at Werezi Africa's largest book ecommerce store. The book was published by Royal Society of Chemistry and it has pages.